Skip to main
MGRM
MGRM logo

MGRM Earnings Dates & Reports

MGRM Most Recent Earnings

Report DateAug 15, 2025
Period EndingQ2 2025
Est. EPS-$0.11
Actual EPS-$0.16
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MGRM Earnings per Share (EPS) History

Signup for full access
Browse free

MGRM Latest Earnings

The value each MGRM share was expected to gain vs. the value each share gained.

MGRM reported its most recent earnings on Aug 15, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.16. This exceeded analysts' expectations of -$0.11 by 45.45%, marking a Miss.

For comparison, Monogram Orthopaedics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 11/13/2025, with analysts projecting an EPS of -$0.16.

MGRM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 18, 2025
-$0.16Next earnings call Nov. 13, 2025
Q2 2025Aug 15, 2025
-$0.11-$0.16+45.45%

MGRM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Monogram Orthopaedics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 15, 2025

MGRM Earnings FAQs

MGRM last reported earnings on Aug 15, 2025 for Q2 2025, posting an EPS of -$0.16, which Miss the estimate of -$0.11 by 45.45%.

For Q2 2025, MGRM reported an EPS of -$0.16, missing analysts' estimate of -$0.11 by 45.45%.

For Q2 2025, MGRM Miss expectations with an actual EPS of -$0.16 vs. an estimated EPS of -$0.11.

Following the last earnings report on Aug 15, 2025, MGRM's stock price moved — from — to —.

The next MGRM earnings call is scheduled for Nov. 13, 2025, where executives will discuss financial results and outlook.

Monogram Orthopaedics Inc (MGRM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.